Food and Drug Administration

Advisory Committee for Reproductive Health Drugs

September 30, 2003


Neuroendocrine Control of the Menstrual Cycle and Associated Disorders, Dr. James Liu, MD, et. al. (HTM) (PPT)

Genetics of Hypogonadotropic Hypogonadism, Dr. Lawrence Layman, MD, The Medical College of Georgia (HTM) (PPT)


The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Slide Presentation Regarding Luveris® (llutropin alfa for injection), Serono, Inc. (HTM) (PPT)

Luveris™: The FDa Perspective, Dr. Shelley Slaughter, MD, PhD, FDA (HTM) (PPT)

Luveris® New Drug Application (21-322), Kate Meaker, MS, FDA (HTM) (PPT)